Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Researchers claim patients infected with COVID-19 more likely to survive if consumed SSRIs

Staff Writer
Staff Writer 2 years ago
Updated 2021/11/16 at 3:22 AM
Share
SHARE

A study published online in JAMA claimed that people infected with COVID-19 who were already taking SSRI antidepressants were at a lower likelihood of dying from the virus.

The study began by analyzing the electronic health records of nearly 500,000 patients within the United States. At least 80,000 adult patients infected with COVID-19 took part in the study.

“This retrospective cohort study used propensity score matching by demographic characteristics, comorbidities, and medication indication to compare SSRI-treated patients with matched control patients not treated with SSRIs within a large EHR database representing a diverse population of 83,584 patients diagnosed with COVID-19 from January to September 2020 and with a duration of follow-up of as long as 8 months in 87 health care centers across the US,” the study’s authors explained in the JAMA report.

After assessing the SSRI drug fluoxetine, researchers learned that 28 percent of patients with COVID-19 were less likely to experience death. The reduction was also observed among patients taking fluvoxamine.

“These results support evidence that SSRIs may be associated with reduced severity of COVID-19 reflected in the reduced RR of mortality,” according to the study’s authors.

“Further research and randomized clinical trials are needed to elucidate the effect of SSRIs generally, or more specifically of fluoxetine and fluvoxamine, on the severity of COVID-19 outcomes.”

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

TAGGED: COVID-19, drugs, SSRIs
Staff Writer November 15, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Enriched formula milk consumption does not enhance academic performance later in adolescence
Next Article Consuming coffee or tea might be associated with a reduced risk of dementia and stroke

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?